Relapse Predictors in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a group of rare diseases with a chronic and relapsing course. Recent treatment guidelines offer many therapeutic options depending mainly on the type of diagnosis and disease manifestations. Areas that remain under discuss...

Full description

Bibliographic Details
Published in:	Diagnostics
Main Authors:	Katarzyna Wawrzycka-Adamczyk, Mariusz Korkosz, Jacek Musiał, Krzysztof Wójcik
Format:	Article
Language:	English
Published:	MDPI AG 2024-08-01
Subjects:	vasculitis relapse predictors
Online Access:	https://www.mdpi.com/2075-4418/14/17/1849

Similar Items

ANCA-Associated Vasculitis Clinical Presentation and Clinical Predictors of Relapse in Saudi Arabia
by: Alahmari H, et al.
Published: (2021-07-01)

Neutrophils and Platelets as Key Players in the Pathogenesis of ANCA-Associated Vasculitis and Potential Sources of Disease Activity Biomarkers
by: Anna Drynda, et al.
Published: (2025-07-01)

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination
by: Saki Okuda, et al.
Published: (2021-07-01)

Antineutrophil cytoplasmic antibody-associated vasculitis: insights into relapse risk and future management directions
by: Federico Alberici, et al.
Published: (2025-09-01)

Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population
by: Aya Kawasaki, et al.
Published: (2023-03-01)

Minocycline-induced antineutrophil cytoplasmic antibody-associated vasculitis in children
by: Sunil Kapur, et al.
Published: (2021-01-01)

Malignancy is increased in patients with antineutrophil cytoplasmic antibody-associated vasculitis in China
by: Xiang-Yu Han, et al.
Published: (2024-05-01)

Antineutrophil Cytoplasmic Antibody (ANCA)-associated vasculitis following COVID-19 BBIBP-CorV vaccine: A case report
by: Parisa Javadian, et al.
Published: (2024-01-01)

Treatment of severe perinuclear antineutrophil cytoplasmic antibody–associated vasculitis with efgartigimod
by: Afsoon Ghafari-Saravi, BS, et al.
Published: (2024-05-01)

Serum calprotectin in vasculitis associated with antineutrophil cytoplasmic antibodies
by: E. N. Vorkel, et al.
Published: (2024-08-01)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
by: E. N. Vorkel, et al.
Published: (2024-12-01)

Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis
by: Megan M. Sullivan, et al.
Published: (2024-01-01)

Clinical analysis of 41 cases of antineutrophil cytoplasmic antibody associated vasculitis
by: GAO Qi, et al.
Published: (2018-01-01)

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis with Renal and Lung Involvement
by: Albert Hing Wong, et al.
Published: (2022-06-01)

Investigating potential biomarkers associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis using Mendelian randomization and transcriptomic analysis
by: Yujia Wang, et al.
Published: (2025-08-01)

Clinical perspective on serum periostin in antineutrophil-cytoplasmic antibody-associated vasculitis
by: Taejun Yoon, et al.
Published: (2025-05-01)

Profiles of cytokines in patients with antineutrophil cytoplasmic antibody-associated vasculitis
by: Weiwei Hao, et al.
Published: (2024-07-01)

Cardiovascular disease and antineutrophil cytoplasmic antibodies-associated vasculitis: A systematic review
by: Amal H. Mohamed, et al.
Published: (2024-08-01)

Rituximab in relapsed/refractory antineutrophil cytoplasmic antibody associated vasculitis: A single-center prospective observational study
by: Ekbote Gayatri, et al.
Published: (2019-01-01)

Pulmonary aspergillosis associated with antineutrophil cytoplasmic antibody-positive vasculitis involving skin and peripheral nerves
by: Abhijith Rajaram Rao, et al.
Published: (2024-01-01)

Pulmonary-Renal Syndrome from Levamisole-Adulterated Cocaine-Induced Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Systematic Review
by: Philip Bucur, et al.
Published: (2023-06-01)

Clinical value at baseline and follow-up of myeloperoxidase-antibodies in ANCA-associated vasculitis
by: Gabriel Bossan, et al.
Published: (2025-09-01)

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives
by: Zdenka Hruskova, et al.
Published: (2020-02-01)

Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis in chronic Hepatitis B: Unraveling the immune puzzle - a rare case report with review of literature
by: Suresh Bhagoowani, et al.
Published: (2024-01-01)

Pulmonary and Renal Predictors of Mortality in ANCA-Associated Vasculitis: A Regional Experience from Türkiye
by: Dilara Bulut Gökten, et al.
Published: (2025-06-01)

Antineutrophil cytoplasmic antibody-associated vasculitis in a patient with diffuse scleroderma
by: B N Shiva Prasad, et al.
Published: (2021-01-01)

On the epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in the adult population of Russia
by: O. N. Egorova, et al.
Published: (2025-06-01)

Combination Cyclophosphamide and Rituximab to Minimize Glucocorticoid Use in Antineutrophil Cytoplasm Antibody–Associated Vasculitis
by: Tania Salehi, et al.
Published: (2025-07-01)

CCL23 is a potential biomarker for antineutrophil cytoplasmic antibody–associated vasculitis
by: Weiwei Hao, et al.
Published: (2025-04-01)

Impact of different ANCA serotypes on the long-term outcome of ANCA-associated vasculitis patients
by: Fumin Qi, et al.
Published: (2023-12-01)

Clinical Characteristics, Predictors for Mortality and Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score on Survival in ANCA-Associated Vasculitis in Hong Kong
by: Joshua Ka Ho Yeung, et al.
Published: (2024-07-01)

Pediatric antineutrophil cytoplasmic antibody-associated vasculitis: A review on pulmonary manifestations, management, and outcomes
by: Chien-Heng Lin, et al.
Published: (2024-09-01)

Damage to the organ of hearing and upper respiratory tract in vasculitis associated with antineutrophil cytoplasmic antibodies
by: A. A. Klimenko, et al.
Published: (2024-08-01)

Outcomes After Kidney Transplantation in Antineutrophil Cytoplasmic Autoantibody–Associated Renal Vasculitis
by: Marine Dekervel, et al.
Published: (2025-10-01)

Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
by: Reza Zonozi, et al.
Published: (2024-06-01)

Examining the role of patient-reported external factors and risk of relapse in anti-neutrophilic cytoplasmic autoantibody vasculitis
by: Mary M. Collie, et al.
Published: (2024-07-01)

Cytoplasmic Pattern Anti-neutrophil Cytoplasmic Antibody (cANCA)-positive Cutaneous Leukocytoclastic Vasculitis Induced by Propylthiouracil: A Case Report
by: Gulsah Elbuken, et al.
Published: (2016-06-01)

Clinical features and outcomes of elderly patients with antineutrophil cytoplasmic antibody-positive vasculitis: a single-center retrospective study
by: Hyo Jin Kim, et al.
Published: (2022-03-01)

Infective endocarditis mimicking antineutrophil-cytoplasmic-antibody-associated vasculitis with glomerulonephritis: a case report
by: Ahmad Matarneh, et al.
Published: (2025-08-01)

Serum interleukin-18 level in patients with antineutrophil cytoplasmic antibodies associated vasculitis and implication
by: CAI Juan, et al.
Published: (2015-01-01)